-
1.发明公开A NOVEL CONCEPT TO REDUCE LEFT ATRIAL PRESSURE IN SYSTOLIC AND DIASTOLIC HF PATIENTS TO TREAT PULMONARY EDEMA AND REDUCE HOSPITALIZATION RATES 审中-公开一种新的概念，用于降低体循环和阵发性HF患者的左心房压力，以治疗肺水肿并降低住院率
公开(公告)号：EP3253297A1
公开(公告)日：2017-12-13
申请号：EP16713136.6
申请日：2016-02-04
发明人： ANAND, Umang , GOEL, Raghav , MCGOWAN, Roger , ROSS, Daniel , HAVERKOST, Patrick , BYRON, Mary , WULFMAN, David R. , ROHL, James , POLLAK, Peter M. , OLSON, Lyle , BEHFAR, Atta , BRUCE, Charles
CPC分类号： A61B17/0057 , A61B2017/00575 , A61B2017/00592 , A61B2017/00597 , A61B2017/00606 , A61B2017/00623 , A61F2/24 , A61F2210/0014 , A61F2230/0069
摘要： Devices provided herein can include implantable transseptal flow control components adapted to be implanted in an opening in a septal wall. In a closed configuration, the implantable transseptal flow control components provided herein prevent blood from flowing through the opening. In an open configuration, the implantable transseptal flow control components provided herein allow blood to flow from the left atrium to the right atrium. In a closed configuration, implantable transseptal flow control components provided herein can be configured such that blood does not stagnate at a location proximate to a left atrium flow control component side when the pressure differential is below a second predetermined threshold pressure value. Implantable transseptal flow control components provided herein can remain in a closed configuration when a pressure differential between the left atrium and the right atrium is less than a first non-zero predetermined threshold pressure value.
-
-
公开(公告)号：EP3630014A1
公开(公告)日：2020-04-08
申请号：EP18806946.2
申请日：2018-05-25
发明人： YU, Victor, San Hou , ANAND, Umang , COLES, George, L. , BEATY, James, Duncan , BULKIN, Keith , WALTERS, Joseph, A. , HARRIGAN, Timothy, P. , RENGARAJAN, Ramji , APKARIAN, Kalyna , JANCARIC, Tom , ROTH, Reggie , CAWTHRA, James , WERNER, Dennis , KILVINGTON, Jason , ZEHR, Kenton, J. , CRAWFORD, Christopher, Todd
IPC分类号： A61F2/24
-
公开(公告)号：EP4126188A1
公开(公告)日：2023-02-08
申请号：EP21715457.4
申请日：2021-03-11
发明人： ANAND, Umang , MEREDITH, Ian
IPC分类号： A61M60/135 , A61M60/295 , A61M25/00 , A61M60/515 , A61M60/523 , A61M60/531
-
公开(公告)号：EP3886766A1
公开(公告)日：2021-10-06
申请号：EP19821406.6
申请日：2019-11-26
发明人： SCONZERT, Kalyna L. , JANCARIC, Thomas P. , ROTH, Reggie , ANAND, Umang , WERNER, Dennis B. , KILVINGTON, Jason A. , CAWTHRA, JR., James K.
IPC分类号： A61F2/24
-
公开(公告)号：EP4291287A1
公开(公告)日：2023-12-20
申请号：EP22721564.7
申请日：2022-04-14
IPC分类号： A61M60/237 , A61M60/865 , A61M60/13
-
7.发明公开
公开(公告)号：EP2326360A2
公开(公告)日：2011-06-01
申请号：EP09791720.7
申请日：2009-08-20
发明人： PRIEBE, Tom , ANAND, Umang , GIBSON, Lance , CLAPP, Les , KUEHLING, Michael
CPC分类号： A61L27/34 , A61L27/50 , A61L27/54 , A61L31/10 , A61L31/14 , A61L31/16 , A61L2300/606 , C08L101/12
摘要： Medical devices having a coating comprising an ionic polymer for electromagnetically- controlled release of a therapeutic agent. Release of the therapeutic agent from the coating is facilitated or modulated by the application of an electromagnetic field to the medical device. Exposure to the electromagnetic field may cause the release of the therapeutic agent in various ways, including electrochemical changes in the ionic polymer, structural changes in the coating and/or ionic polymers, changes in the permeability of the coating, changes in the orientation of the ionic polymers, or motion of the ionic polymers. Also disclosed are methods for delivering a therapeutic agent using electromagnetic fields.
-
-
-
-
-
-
搜索结果
7 条记录 (耗时 0.013 秒)
